주요국의 의약품 급여관리를 위한 수평탐색 현황 비교

With the recent development of innovative medical technology, the market entry of high-priced drugs, such as Kymriah, Zolgensma, and Luxturna injections, is increasing. Accordingly, there is a growing need to effectively manage benefits by reviewing the characteristics of drugs, significant adverse...

Full description

Saved in:
Bibliographic Details
Published inHIRA Research Vol. 4; no. 1; pp. 20 - 33
Main Authors 조쌍은, Ssangeun Jo, 변지혜, Ji-hye Byun
Format Journal Article
LanguageKorean
Published 건강보험심사평가원 심사평가정책연구소 31.05.2024
건강보험심사평가원
Subjects
Online AccessGet full text
ISSN2765-6764
2765-7353
DOI10.52937/hira.24.4.1.e6

Cover

Abstract With the recent development of innovative medical technology, the market entry of high-priced drugs, such as Kymriah, Zolgensma, and Luxturna injections, is increasing. Accordingly, there is a growing need to effectively manage benefits by reviewing the characteristics of drugs, significant adverse reactions, and treatment effects in advance through horizon scanning. This study conducts a literature review of the status and methodology of domestic and foreign horizon scanning and proposes horizon scanning methods for pharmaceutical benefits management. The review results indicate that horizon scanning in Europe had different operational plans, such as the scope and duration of the search by country. However, the implementation typically aimed to reflect horizon scanning in policy decisions, such as determining benefits directions or establishing a regulatory agency management plan. Meanwhile, the results of horizon scanning in the United States and Korea were provided as reference materials to major stakeholders rather than directly reflecting them in the policy. Although listing high-priced drugs with uncertain long-term treatment effects and financial impact is expected to increase, periodic horizon scanning activities for pharmaceutical benefits management have not been conducted in Korea. Therefore, as a horizon scanning procedure for pharmaceutical benefits management, this study proposes the following four steps, namely, (step 1) define target indications and drug efficacy groups; (step 2) establish the purpose of horizon scanning; (step 3) review the extant literature; (step 4) summarize and discuss the results; (step 5) deliberate potential decision-making.
AbstractList With the recent development of innovative medical technology, the market entry of high-priced drugs, such as Kymriah, Zolgensma, and Luxturna injections, is increasing. Accordingly, there is a growing need to effectively manage benefits by reviewing the characteristics of drugs, significant adverse reactions, and treatment effects in advance through horizon scanning. This study conducts a literature review of the status and methodology of domestic and foreign horizon scanning and proposes horizon scanning methods for pharmaceutical benefits management. The review results indicate that horizon scanning in Europe had different operational plans, such as the scope and duration of the search by country. However, the implementation typically aimed to reflect horizon scanning in policy decisions, such as determining benefits directions or establishing a regulatory agency management plan. Meanwhile, the results of horizon scanning in the United States and Korea were provided as reference materials to major stakeholders rather than directly reflecting them in the policy. Although listing high-priced drugs with uncertain long-term treatment effects and financial impact is expected to increase, periodic horizon scanning activities for pharmaceutical benefits management have not been conducted in Korea. Therefore, as a horizon scanning procedure for pharmaceutical benefits management, this study proposes the following four steps, namely, (step 1) define target indications and drug efficacy groups; (step 2) establish the purpose of horizon scanning; (step 3) review the extant literature; (step 4) summarize and discuss the results; (step 5) deliberate potential decision-making.
With the recent development of innovative medical technology, the market entry of high-priced drugs, such as Kymriah, Zolgensma, and Luxturna injections, is increasing. Accordingly, there is a growing need to effectively manage benefits by reviewing the characteristics of drugs, significant adverse reactions, and treatment effects in advance through horizon scanning. This study conducts a literature review of the status and methodology of domestic and foreign horizon scanning and proposes horizon scanning methods for pharmaceutical benefits management. The review results indicate that horizon scanning in Europe had different operational plans, such as the scope and duration of the search by country. However, the implementation typically aimed to reflect horizon scanning in policy decisions, such as determining benefits directions or establishing a regulatory agency management plan. Meanwhile, the results of horizon scanning in the United States and Korea were provided as reference materials to major stakeholders rather than directly reflecting them in the policy. Although listing high-priced drugs with uncertain long-term treatment effects and financial impact is expected to increase, periodic horizon scanning activities for pharmaceutical benefits management have not been conducted in Korea. Therefore, as a horizon scanning procedure for pharmaceutical benefits management, this study proposes the following four steps, namely, (step 1) define target indications and drug efficacy groups; (step 2) establish the purpose of horizon scanning; (step 3) review the extant literature; (step 4) summarize and discuss the results; (step 5) deliberate potential decision-making. KCI Citation Count: 0
Author Ssangeun Jo
변지혜
Ji-hye Byun
조쌍은
Author_xml – sequence: 1
  fullname: 조쌍은
– sequence: 2
  fullname: Ssangeun Jo
– sequence: 3
  fullname: 변지혜
– sequence: 4
  fullname: Ji-hye Byun
BackLink https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART003086804$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNotj09LAkEAxYcwyMxzhy57Dnab_-MeRSoFIQjvw7i7U8uWxu6pW6AHPSWSZGGnKAjsllBgX2id_Q4tKY_He4cfD94uKHS6nQCAfQQdhl0iji7DWDmYOtRBTsC3QBELzmxBGClsOhec7oBykoRtyKAgGENYBHXzujTPD-ni07xMrdxm8puNB1b6PTSP8_TrbvU-X70tLTPrZ5OZZQbT7H6Y9UamN7SyaT97-rBWP_10MdoD21pdJUF5kyXQOjlu1ep28-y0Uas27YgxamOSi3sKVpSnPY4IIX7AK9jjKvCVFoFmkLcR0772KhRygqHLc5r6irexwKQEDteznVjLyAtlV4X_edGVUSyr562GRPk_FyOawwdrOAqTRN7E4bWKbyWFLoMIkT8EdXDn
ContentType Journal Article
DBID HZB
Q5X
ACYCR
DOI 10.52937/hira.24.4.1.e6
DatabaseName 한국학술정보 KISS
Korean Studies Information Service System (KISS) B-Type
Korean Citation Index
DatabaseTitleList

DeliveryMethod fulltext_linktorsrc
DocumentTitleAlternate 주요국의 의약품 급여관리를 위한 수평탐색 현황 비교
Comparison of Horizon Scanning Status for Pharmaceutical Benefits Management
EISSN 2765-7353
EndPage 33
ExternalDocumentID oai_kci_go_kr_ARTI_10509214
4095011
GroupedDBID ALMA_UNASSIGNED_HOLDINGS
HZB
Q5X
ACYCR
ID FETCH-LOGICAL-k554-232326ca08acfc61333de682c6aedaf7ef506b15fdfc840632096a084da6b2723
ISSN 2765-6764
IngestDate Sun Jun 22 03:10:38 EDT 2025
Tue Dec 31 02:19:51 EST 2024
IsPeerReviewed false
IsScholarly false
Issue 1
Language Korean
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-k554-232326ca08acfc61333de682c6aedaf7ef506b15fdfc840632096a084da6b2723
Notes Health Insurance Review & Assessment Service
https://www.hira-research.or.kr/journal/view.html?pn=current_issue&uid=955&vmd=Full
PageCount 14
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_10509214
kiss_primary_4095011
PublicationCentury 2000
PublicationDate 20240531
PublicationDateYYYYMMDD 2024-05-31
PublicationDate_xml – month: 05
  year: 2024
  text: 20240531
  day: 31
PublicationDecade 2020
PublicationTitle HIRA Research
PublicationTitleAlternate HIRA Research
PublicationYear 2024
Publisher 건강보험심사평가원 심사평가정책연구소
건강보험심사평가원
Publisher_xml – name: 건강보험심사평가원 심사평가정책연구소
– name: 건강보험심사평가원
SSID ssib050732200
ssib051086599
Score 1.8846096
Snippet With the recent development of innovative medical technology, the market entry of high-priced drugs, such as Kymriah, Zolgensma, and Luxturna injections, is...
SourceID nrf
kiss
SourceType Open Website
Publisher
StartPage 20
SubjectTerms Decision support systems
Emerging therapeutics
Horizon scanning
Insurance
pharmaceutical
Pharmaceutical policy
services
사회학
Title 주요국의 의약품 급여관리를 위한 수평탐색 현황 비교
URI https://kiss.kstudy.com/ExternalLink/Ar?key=4095011
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART003086804
Volume 4
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX HIRA Research, 2024, 4(1), , pp.20-33
journalDatabaseRights – providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 2765-7353
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssib050732200
  issn: 2765-6764
  databaseCode: M~E
  dateStart: 20210101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR1Na9RANNR68SJKFesXATunkphkZpLJMclu2Qr1ICv0tuRTy8JuWbcXDyJ0D92TRSyuUk-iINSbBYX6h3aT_-Cbl_1qKVKF3fDy5s3Me_OGmfcyM28UZYVFYZiYPNGSWKQaYzzURESpBl3Z4XYGYyIeH9t4bNeeskebfHPh0srcrqWdbqTHL889V_I_WgUc6FWekv0HzU4LBQTAoF94gobheSEdk2pAPEr8QAKuR1xGqh7xOfEqiKkQV6xOIQQ48SENXi0iZBqQCyJcTHOIFyCGyf0PVZ94NmIAgGxBWVJABMMCOMCIEgILrxCxhiUBQIlrYBIFzCqSi0k-l3gS5RPfRRQyXF7mObGSa-tPvOmeQNkJmAwnNffRAgU3iV9WAr-JvMKYkUANFAUBWgcBZMMN5r90WGyySD_um8iQKdtAAoaUsyzJL9l3xi0pfGwbACwEpuJjrrJa158IhkOt5djyCEYZT11PZziHcjo_vBtzhkIZwOPsFMTBfpKr4M-3OqFuMZ3ppp6eE-z7zCR8Ktx3M95qPGs3mp0GODXrDVPG6LHkbe2XgSlLXlCy8ao6GTXBoIdBeRZkkcu7szhenDoVq4xphaw9PM0YWCLgqLwAy6rVyeYsq_o15erYJVK9sn9fVxaa7SWlln8-yT--Gx5_zz8NVPjnB7-Lt3vq8Gc_f380_PF69PVo9OVEzQ97xcGhmu8Nijf9Ync_3-2rxaBXfPimjn71hsf7N5T6WrUe1LTxrR9aE0xbDSx88Cji0BBhnMVgbFKapLawYjtMkzBz0owbdmTyLMliAdYotcAJB2qWhHZkORa9qSy22q30lqJyizlGHJtmkpksDlMRCZrKdZA4pa7N6bKyJGVvbJdxXRoM3A2Y7paVB9AWqIS_KOP2hajuKFdmPfmustjt7KT3wIrtRvdRiX8Aj51_Ww
linkProvider ISSN International Centre
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%EC%A3%BC%EC%9A%94%EA%B5%AD%EC%9D%98+%EC%9D%98%EC%95%BD%ED%92%88+%EA%B8%89%EC%97%AC%EA%B4%80%EB%A6%AC%EB%A5%BC+%EC%9C%84%ED%95%9C+%EC%88%98%ED%8F%89%ED%83%90%EC%83%89+%ED%98%84%ED%99%A9+%EB%B9%84%EA%B5%90&rft.jtitle=HIRA+Research%2C+4%281%29&rft.au=%EC%A1%B0%EC%8C%8D%EC%9D%80&rft.au=%EB%B3%80%EC%A7%80%ED%98%9C&rft.date=2024-05-31&rft.pub=%EA%B1%B4%EA%B0%95%EB%B3%B4%ED%97%98%EC%8B%AC%EC%82%AC%ED%8F%89%EA%B0%80%EC%9B%90&rft.issn=2765-6764&rft.eissn=2765-7353&rft.spage=20&rft.epage=33&rft_id=info:doi/10.52937%2Fhira.24.4.1.e6&rft.externalDBID=n%2Fa&rft.externalDocID=oai_kci_go_kr_ARTI_10509214
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2765-6764&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2765-6764&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2765-6764&client=summon